CLIENT SUCCESS: ICECURE MEDICAL GROWS SALES IN ASIAN MARKETS
Asia Actual assists IceCure in achieving goals for continued expansion in Asia
If you are not happy with the results below please do another search
Asia Actual assists IceCure in achieving goals for continued expansion in Asia
The Thai government has voiced their commitment to ending the epidemic by supporting preventative awareness, access to cost-effective tests and treatment resources through public investment and/or private partnerships.
In the wake of the COVID-19 outbreak, the Thai FDA announced on March 5, 2020 that they will cancel their plans to begin regulating alcohol gel sanitizers as medical devices.
Hong Kong’s Department of Health officially changed the name of the Medical Device Control Office (MDCO) to the Medical Device Division (MDD) at the end of 2019.
Learn about the significant opportunities and challenges medical device companies can expect when accessing this dynamic and thriving market.
With Regulation B.E. 2562 (revision from regulation B.E. 2540), the Thai FDA increased the regulatory status of breast implants from Notified to Licensed (Class 4)